Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation

J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13.

Authors

Toshiaki Iba¹, Jerrold H Levy², Theodore E Warkentin³, Jecko Thachil⁴, Tom van der Poll⁵, Marcel Levi⁶; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis

Affiliations

¹ Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC, USA.
³ Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁴ Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
⁵ Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
⁶ University College London Hospitals NHS Foundation Trust, London, UK.

PMID: 31410983
DOI: 10.1111/jth.14578

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't
Review

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Blood Coagulation / drug effects*
Blood Coagulation Tests*
Disseminated Intravascular Coagulation / blood
Disseminated Intravascular Coagulation / diagnosis*
Disseminated Intravascular Coagulation / drug therapy*
Disseminated Intravascular Coagulation / etiology
Humans
Predictive Value of Tests
Sepsis / blood
Sepsis / complications*
Sepsis / diagnosis
Thrombophilia / blood
Thrombophilia / diagnosis*
Thrombophilia / drug therapy*
Thrombophilia / etiology
Treatment Outcome

Substances

Anticoagulants